183 related articles for article (PubMed ID: 23100277)
1. Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency.
Bottega R; Pecci A; De Candia E; Pujol-Moix N; Heller PG; Noris P; De Rocco D; Podda GM; Glembotsky AC; Cattaneo M; Balduini CL; Savoia A
Haematologica; 2013 Jun; 98(6):868-74. PubMed ID: 23100277
[TBL] [Abstract][Full Text] [Related]
2. NBEAL2 mutations and bleeding in patients with gray platelet syndrome.
Pluthero FG; Di Paola J; Carcao MD; Kahr WHA
Platelets; 2018 Sep; 29(6):632-635. PubMed ID: 29869935
[TBL] [Abstract][Full Text] [Related]
3. Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice.
Kahr WH; Lo RW; Li L; Pluthero FG; Christensen H; Ni R; Vaezzadeh N; Hawkins CE; Weyrich AS; Di Paola J; Landolt-Marticorena C; Gross PL
Blood; 2013 Nov; 122(19):3349-58. PubMed ID: 23861251
[TBL] [Abstract][Full Text] [Related]
4. A novel nonsense NBEAL2 gene mutation causing severe bleeding in a patient with gray platelet syndrome.
Cao L; Su J; Li J; Yu Z; Bai X; Wang Z; Xia L; Ruan C
Platelets; 2018 May; 29(3):288-291. PubMed ID: 28504079
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancer.
Wijgaerts A; Wittevrongel C; Thys C; Devos T; Peerlinck K; Tijssen MR; Van Geet C; Freson K
Haematologica; 2017 Apr; 102(4):695-706. PubMed ID: 28082341
[TBL] [Abstract][Full Text] [Related]
6. Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice.
Guerrero JA; Bennett C; van der Weyden L; McKinney H; Chin M; Nurden P; McIntyre Z; Cambridge EL; Estabel J; Wardle-Jones H; Speak AO; Erber WN; Rendon A; Ouwehand WH; Ghevaert C
Blood; 2014 Dec; 124(24):3624-35. PubMed ID: 25258341
[TBL] [Abstract][Full Text] [Related]
7. Nbeal2 Deficiency Increases Organ Damage but Does Not Affect Host Defense During Gram-Negative Pneumonia-Derived Sepsis.
Claushuis TAM; de Stoppelaar SF; de Vos AF; Grootemaat AE; van der Wel NN; Roelofs JJTH; Ware J; Van't Veer C; van der Poll T
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1772-1784. PubMed ID: 29930006
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous 8bp Deletion in Nbeal2 Recapitulates the Gray Platelet Syndrome in Mice.
Tomberg K; Khoriaty R; Westrick RJ; Fairfield HE; Reinholdt LG; Brodsky GL; Davizon-Castillo P; Ginsburg D; Di Paola J
PLoS One; 2016; 11(3):e0150852. PubMed ID: 26950939
[TBL] [Abstract][Full Text] [Related]
9. Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients.
Di Buduo CA; Alberelli MA; Glembostky AC; Podda G; Lev PR; Cattaneo M; Landolfi R; Heller PG; Balduini A; De Candia E
Sci Rep; 2016 Mar; 6():23213. PubMed ID: 26987485
[TBL] [Abstract][Full Text] [Related]
10. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules.
Gunay-Aygun M; Falik-Zaccai TC; Vilboux T; Zivony-Elboum Y; Gumruk F; Cetin M; Khayat M; Boerkoel CF; Kfir N; Huang Y; Maynard D; Dorward H; Berger K; Kleta R; Anikster Y; Arat M; Freiberg AS; Kehrel BE; Jurk K; Cruz P; Mullikin JC; White JG; Huizing M; Gahl WA
Nat Genet; 2011 Jul; 43(8):732-4. PubMed ID: 21765412
[TBL] [Abstract][Full Text] [Related]
11. α-granule biogenesis: from disease to discovery.
Chen CH; Lo RW; Urban D; Pluthero FG; Kahr WH
Platelets; 2017 Mar; 28(2):147-154. PubMed ID: 28277061
[TBL] [Abstract][Full Text] [Related]
12. Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome.
Larocca LM; Heller PG; Podda G; Pujol-Moix N; Glembotsky AC; Pecci A; Alberelli MA; Balduini CL; Landolfi R; Cattaneo M; De Candia E
Platelets; 2015; 26(8):751-7. PubMed ID: 25806575
[TBL] [Abstract][Full Text] [Related]
13. Gray Platelet Syndrome Presenting With Pancytopenia, Splenomegaly, and Bone Marrow Fibrosis.
Tariq H; Perez Botero J; Higgins RA; Medina EA
Am J Clin Pathol; 2021 Jul; 156(2):253-258. PubMed ID: 33586768
[TBL] [Abstract][Full Text] [Related]
14. NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cells.
Delage L; Carbone F; Riller Q; Zachayus JL; Kerbellec E; Buzy A; Stolzenberg MC; Luka M; de Cevins C; Kalouche G; Favier R; Michel A; Meynier S; Corneau A; Evrard C; Neveux N; Roudières S; Pérot BP; Fusaro M; Lenoir C; Pellé O; Parisot M; Bras M; Héritier S; Leverger G; Korganow AS; Picard C; Latour S; Collet B; Fischer A; Neven B; Magérus A; Ménager M; Pasquier B; Rieux-Laucat F
Nat Commun; 2023 Jun; 14(1):3728. PubMed ID: 37349339
[TBL] [Abstract][Full Text] [Related]
15. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome.
Kahr WH; Hinckley J; Li L; Schwertz H; Christensen H; Rowley JW; Pluthero FG; Urban D; Fabbro S; Nixon B; Gadzinski R; Storck M; Wang K; Ryu GY; Jobe SM; Schutte BC; Moseley J; Loughran NB; Parkinson J; Weyrich AS; Di Paola J
Nat Genet; 2011 Jul; 43(8):738-40. PubMed ID: 21765413
[TBL] [Abstract][Full Text] [Related]
16. NBEAL2 is required for neutrophil and NK cell function and pathogen defense.
Sowerby JM; Thomas DC; Clare S; Espéli M; Guerrero JA; Hoenderdos K; Harcourt K; Marsden M; Abdul-Karim J; Clement M; Antrobus R; Umrania Y; Barton PR; Flint SM; Juss JK; Condliffe AM; Lyons PA; Humphreys IR; Chilvers ER; Ouwehand WH; Dougan G; Smith KG
J Clin Invest; 2017 Sep; 127(9):3521-3526. PubMed ID: 28783043
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome.
Albers CA; Cvejic A; Favier R; Bouwmans EE; Alessi MC; Bertone P; Jordan G; Kettleborough RN; Kiddle G; Kostadima M; Read RJ; Sipos B; Sivapalaratnam S; Smethurst PA; Stephens J; Voss K; Nurden A; Rendon A; Nurden P; Ouwehand WH
Nat Genet; 2011 Jul; 43(8):735-7. PubMed ID: 21765411
[TBL] [Abstract][Full Text] [Related]
18. The endoplasmic reticulum protein SEC22B interacts with NBEAL2 and is required for megakaryocyte α-granule biogenesis.
Lo RW; Li L; Pluthero FG; Leung R; Eto K; Kahr WHA
Blood; 2020 Aug; 136(6):715-725. PubMed ID: 32384141
[TBL] [Abstract][Full Text] [Related]
19. Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.
Sims MC; Mayer L; Collins JH; Bariana TK; Megy K; Lavenu-Bombled C; Seyres D; Kollipara L; Burden FS; Greene D; Lee D; Rodriguez-Romera A; Alessi MC; Astle WJ; Bahou WF; Bury L; Chalmers E; Da Silva R; De Candia E; Deevi SVV; Farrow S; Gomez K; Grassi L; Greinacher A; Gresele P; Hart D; Hurtaud MF; Kelly AM; Kerr R; Le Quellec S; Leblanc T; Leinøe EB; Mapeta R; McKinney H; Michelson AD; Morais S; Nugent D; Papadia S; Park SJ; Pasi J; Podda GM; Poon MC; Reed R; Sekhar M; Shalev H; Sivapalaratnam S; Steinberg-Shemer O; Stephens JC; Tait RC; Turro E; Wu JKM; Zieger B; ; Kuijpers TW; Whetton AD; Sickmann A; Freson K; Downes K; Erber WN; Frontini M; Nurden P; Ouwehand WH; Favier R; Guerrero JA
Blood; 2020 Oct; 136(17):1956-1967. PubMed ID: 32693407
[TBL] [Abstract][Full Text] [Related]
20. The Neurobeachin-like 2 Protein Regulates Mast Cell Homeostasis.
Drube S; Grimlowski R; Deppermann C; Fröbel J; Kraft F; Andreas N; Stegner D; Dudeck J; Weber F; Rödiger M; Göpfert C; Drube J; Reich D; Nieswandt B; Dudeck A; Kamradt T
J Immunol; 2017 Oct; 199(8):2948-2957. PubMed ID: 28887433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
